# PepLog vs PeptidePal

The clearest difference is rating: PepLog at 4.0 against PeptidePal's 3.4. PepLog also leads on monetization model (free vs freemium) and review sentiment (50% vs 33%). PeptidePal's advantage is update cadence (fortnightly vs every 2 months). On price, ratings volume, ads and in-app purchases there is nothing between them.

Both are free to download. PepLog sells 1 one-off in-app purchase and PeptidePal sells 3 in-app purchases, starting at $2.99 per month. Whichever you choose, the download price is not the number that matters.

PepLog holds the better App Store score, 4.0 against 3.4. Both are backed by a comparable volume of ratings — 2 and 5 respectively. Written reviews point the same way: 50% of PepLog's written reviews are positive against 33% of PeptidePal's.

PepLog ships an update every 2 months, PeptidePal fortnightly. The most recent releases landed on September 15, 2026 and October 15, 2026 respectively.

## The numbers

| Metric | PepLog | PeptidePal |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[4.0 (2 ratings)](https://appshunter.io/ios/app/peplog/id6744858000/reviews)** | [3.4 (5 ratings)](https://appshunter.io/ios/app/peptidepal/id6746348113/reviews) |
| Number of ratings | 2 | **5** |
| Positive reviews | **50.0% of reviews** | 33.3% of reviews |
| In-app purchases | Yes | Yes |
| Ads | No | No |
| Update frequency | Every 2 months | **Fortnightly** |
| Monetization | **Free** | Freemium |
| Size | 64 MB | 48 MB |
| Requires iOS | 15.1 | 15.1 |
| Devices | **iPhone, iPad, iPod** | iPhone, iPod |
| Age rating | 17+ | 17+ |
| Developer | [Roberto Yudice](https://appshunter.io/developer/1799605586) | [SIGNALWORKS LABS INC.](https://appshunter.io/developer/1816293557) |

## What reviewers say

### PepLog

[App page](https://appshunter.io/ios/app/peplog/id6744858000)

This app simplifies tracking complex peptide protocols by managing schedules, sending timely reminders, and allowing one-tap dose logging. It supports multiple peptides, provides a full dose history, and estimates supply duration to prevent running out.

**Highlights:** Flexible peptide scheduling, Home screen widget for quick logging, One-tap dose logging, Multi-peptide protocol support, Smart dose reminders, Full dose history, Supply duration calculation

**Features:** macOS Compatibility

**In-app purchases (1)**

| Purchase | Price | Billing |
| --- | --- | --- |
| PepLog Pro Lifetime | $4.99 | one-time |


### PeptidePal

[App page](https://appshunter.io/ios/app/peptidepal/id6746348113)

This app helps users meticulously track research peptides, manage inventory, and schedule doses with smart reminders. It also offers new health tracking features for sleep, supplements, and progress monitoring, with secure data syncing and export options.

**Highlights:** Log doses with a simple swipe, Track multiple peptides simultaneously, Organize peptide stock with low stock alerts, Daily or specific day dose reminders, Monitor sleep patterns and quality, Track weight and body measurements, Export data as CSV for analysis

**In-app purchases (3)**

| Purchase | Price | Billing |
| --- | --- | --- |
| PeptidePal Pro | $2.99 | per month |
| Peptidepal Yearly | $29.99 | per year |
| PeptidePal Pro | $2.99 | one-time |


## Frequently asked questions

### Is PepLog free?

PepLog is free to download, with in-app purchases available.

### Is PeptidePal free?

PeptidePal is free to download, with in-app purchases available.

### Which has better reviews, PepLog or PeptidePal?

PepLog is rated higher. PepLog averages 4.0 out of 5 from 2 ratings, while PeptidePal averages 3.4 from 5 ratings.

### Do PepLog or PeptidePal have ads?

Neither PepLog nor PeptidePal shows ads.

### Which is updated more often, PepLog or PeptidePal?

PepLog ships an update every 2 months, and PeptidePal fortnightly. Most recently, PepLog was updated on September 15, 2026 and PeptidePal on October 15, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*